NURIAM. PASTOR-SOLER Division of Nephrology and Hypertension, Department of
Medicine, USC/UKRO Kidney Research Center, Keck School of Medicine of USC, Los
Angeles, CA, USA
ARNIMPAUSE Goodman Cancer Research Centre, Biochemistry Department, McGill
University, Montreal, Canada
TIPHE`NEPIRNAY Laboratoire d’Immunobiologie, Universite ́ Libre de Bruxelles—IBMM,
Gosselies, Belgium
ELITEPOSSIK Goodman Cancer Research Centre, Biochemistry Department, McGill
University, Montreal, Canada
FRANCISRAJAMOHAN Worldwide Research and Development, Pfizer Inc., Groton, CT, USA
ROSHANRAJANI Division of Nephrology and Hypertension, Department of Medicine, USC/
UKRO Kidney Research Center, Keck School of Medicine of USC, Los Angeles, CA, USA
RENEERAO Division of Nephrology and Hypertension, Department of Medicine, USC/
UKRO Kidney Research Center, Keck School of Medicine of USC, Los Angeles, CA, USA
ALLANR. REYES Worldwide Research and Development, Pfizer Inc., Cambridge, MA, USA
ELMERRHO Cell Biology and Biomedical Engineering, School of Medicine, Johns Hopkins
University, Baltimore, MD, USA
VALENTINROUSTAN Department of Ecogenomics and Systems Biology, University of Vienna,
Vienna, Austria
RICHARDROY Department of Biology, McGill University, Montreal, QC, Canada
FIONAM. RUSSELL Division of Cell Signalling and Immunology, School of Life Sciences,
University of Dundee, Dundee, Scotland, UK
GUYA. RUTTER Section of Cell Biology and Functional Genomics, Division of Diabetes,
Endocrinology and Metabolism, Imperial College London, London, UK
IANP. SALT Institute of Cardiovascular and Medical Sciences, College of Medical,
Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
PASCUALSANZ Instituto de Biomedicina de Valencia, CSIC and Centro de Investigacion
Biome ́dica en Red de Enfermedades Raras (CIBERER), Valencia, Spain
DHRUVSARMA Division of Cardiovascular Medicine, Radcliffe Department of Medicine,
University of Oxford, Oxford, UK; The Wellcome Centre for Human Genetics, University of
Oxford, Oxford, UK
EBERHARDSCHULZ Department of Cardiology 1, Center for Cardiology,
Universit€atsmedizin Mainz, Mainz, Germany
JOHNW. SCOTT Mary MacKillop Institute for Health Research, Australian Catholic
University, Melbourne, VIC, Australia; Protein Chemistry and Metabolism Unit,
St. Vincent’s Institute of Medical Research, Fitzroy, VIC, Australia
WILLIAMSEIBEL Division of Experimental Hematology and Cancer Biology, Cincinnati
Children’s Hospital Medical Center, Cincinnati, OH, USA
PATRICIASEOANE-COLLAZO NeurObesity Group, Department of Physiology, CIMUS,
University of Santiago de Compostela-Instituto de Investigacion Sanitaria, Santiago de
Compostela, Spain; CIBER Fisiopatologı ́a de la Obesidad y Nutricion (CIBERobn),
Santiago de Compostela, Spain
JOHNY.-J. SHYY Department of Medicine, University of California, San Diego, La
Jolla, CA, USA
RICARDOSILVESTRE Life and Health Sciences Research Institute (ICVS), School of Medicine,
University of Minho, Braga, Portugal; ICVS/3Bs-PT Government Associate Laboratory,
Guimara ̃es, Braga, Portugal
Contributors xv